Evaluation of Nystatin Containing Chitosan Hydrogels as Potential Dual Action Bio-Active Restorative Materials: in Vitro Approach
Source abstract
Abstract
Healing is a specific biological process related to the general phenomenon of growth and tissue regeneration and is a process generally affected by several systemic conditions or as detrimental side-effects of chemotherapy- and radiotherapy-induced inflammation of the oral mucosa. The objectives of this study is to evaluate the novel chitosan based functional drug delivery systems, which can be successfully incorporated into “dual action bioactive restorative materials”, capable of inducing in vitro improved wound healing prototype and containing an antibiotic, such as nystatin, krill oil as an antioxidant and hydroxyapatite as a molecular bone scaffold, which is naturally present in bone and is reported to be successfully used in promoting bone integration when implanted as well as promoting healing. The hydrogels were prepared using a protocol as previously reported by us. The physico-chemical features, including surface morphology (SEM), release behaviors, stability of the therapeutic agent-antioxidant-chitosan, were measured and compared to the earlier reported chitosan-antioxidant containing hydrogels. Structural investigations of the reactive surface of the hydrogel are reported. Release of nystatin was investigated for all newly prepared hydrogels. Bio-adhesive studies were performed in order to assess the suitability of these designer materials. Free radical defense capacity of the biomaterials was evaluated using established in vitro model. The bio-adhesive capacity of the materials in the in vitro system was tested and quantified. It was found that the favorable synergistic effect of free radical built-in defense mechanism of the new functional materials increased sustainable bio-adhesion and therefore acted as a functional multi-dimensional restorative material with potential application in wound healing in vitro.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Wound Healing and Treatments · Surgical Sutures and Adhesives
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Research and Development Department, VTPCHEM PTY LTD., Southport 4215, Australia
School of Dentistry and Oral Health, Gold Coast campus, Griffith University, QLD 4222, Australia
School of Material Science and Engineering, East China University of Science and Technology, 130 Meilong Road, Shanghai 200237, China
Oral and Dental Research Institute, Faculty of Dentistry, University of the Western Cape, Private Bag X1, Tygerberg 7505, Cape Town, South Africa
References (40)
Show source-provided references
1. Research advances in oral mucositis10.1097/00001622-199907000-00005 ↗
2. Oral mucositis complicating chemotherapy and/or radiotherapy: Options for prevention and treatment10.3322/canjclin.51.5.290 ↗
3. Chemotherapy-induced and/or radiation therapy-induced oral mucositis—Complicating the treatment of cancer10.1593/neo.04169 ↗
4. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity10.1016/S1368-8375(97)00053-5 ↗
5. Free radicals, antioxidants in diease and health10.59566/IJBS.2008.4089 ↗
6. Free radicals and antioxidants in normal physiological functions and human disease10.1016/j.biocel.2006.07.001 ↗
7. Enhancing effect of chitosan on peptide drug delivery across buccal mucosa10.1016/S0142-9612(00)00134-4 ↗
8. Application of chitosan gel in the treatment of chronic periodontitis10.1002/jbm.b.30596 ↗
9. Alternative chitosan based drug delivery system to fight oral mucositis: Synergy of conventional and bioactives towards the optimal solution10.2174/157341312801784320 ↗
10. Chitosan delivery systems for the treatment of oral mucositis: In vitro and in vivo studies10.1016/j.jconrel.2004.05.002 ↗
11. Novel melatonin-chitosan hydrogels as suitable oral bio-drug delivery systems to fight oral mucositis: Synergy of antioxidants and bioactives in action10.2174/138527212803520173 ↗
12. Functionally gradient chitosan/hydroxyapatite composite scaffolds for controlled drug release10.1002/jbm.b.31283 ↗
13. Wound healing dressings and drug delivery systems: A review10.1002/jps.21210 ↗
14. Role of hydroxyapatite in healing of experimentally induced cutaneous wound in rabbits
15. Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic vancomycin release10.1007/s10856-005-6679-y ↗
16. Chitosan and gelatin based prototype delivery systems for the treatment of oral mucositis: From material to performance in vitro10.2174/1567201811310010020 ↗
17. Antibiotic susceptibility testing by a standardized single disc method10.1093/ajcp/45.4_ts.493 ↗
18. Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine10.1016/j.ejps.2005.11.001 ↗
19. Bioadhesive analysis of controlled-release systems. I. Fracture and interpenetration analysis in poly (acrylic acid)-containing systems10.1016/0168-3659(87)90004-6 ↗
20. In vitro techniques to evaluate buccal films10.1016/j.jconrel.2012.11.019 ↗
21. Reactive oxygen species and antioxidants in inflammatory diseases10.1111/j.1600-051X.1997.tb00760.x ↗
22. LXXIII.—Oxidation of tartaric acid in presence of iron10.1039/CT8946500899 ↗
23. Pyridoindole antioxidant stobadine protected bovine serum albumin against the hydroxyl radical mediated cross-linking in vitro10.1016/S0167-4943(02)00167-X ↗
24. Application of glutaraldehyde-crosslinked chitosan as a scaffold for hepatocyte attachment10.1248/bpb.20.708 ↗
25. Culture and growth characteristics of chondrocytes encapsulated in alginate beads10.3109/03008208909043901 ↗
26. Preparation and histological evaluation of biomimetic three-dimensional hydroxyapatite/chitosan-gelatin network composite scaffolds10.1016/S0142-9612(02)00077-7 ↗
27. Attachment and growth of cultured fibroblast cells on PVA/chitosan-blended hydrogels10.1002/(SICI)1097-4636(19980305)39:3<486::AID-JBM20>3.0.CO;2-7 ↗
28. Tissue engineered bone formation using chitosan/tricalcium phosphate sponges10.1902/jop.2000.71.3.410 ↗
29. Biological activities of chitosan and chitooligosaccharides10.1016/j.foodhyd.2010.03.003 ↗
30. Mucoadhesive: As oral controlled gastroretentive drug delivery system
31. Why is chitosan mucoadhesive?10.1021/bm800276d ↗
32. Mucoadhesives in the gastrointestinal tract: Revisiting the literature for novel applications10.1016/j.ejpb.2005.01.007 ↗
33. Advances in oral transmucosal drug delivery10.1016/j.jconrel.2011.01.027 ↗
34. Williams, S. (1997). Nutrition and Diet Therapy, Mosby–Year Book Inc.
35. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery10.1016/S0378-5173(99)00334-8 ↗
36. Chitosan based sustained release mucoadhesive buccal patches containing verapamil HCL
37. Applications of chitosan and chitosan derivatives in drug delivery
38. Sarmento, B., and das Neves, J. (2012). Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting and Polymer Therapeutics, John Wiley & Sons.10.1002/9781119962977 ↗
39. Factors effect on the loading efficiency of vitamin c loaded chitosan-coated nanoliposomes10.1016/j.colsurfb.2009.09.041 ↗
40. Protective effect of conventional antioxidant (β-carotene, resveratrol and vitamin E) in chitosan-containing hydrogels against oxidative stress and reversal of DNA double stranded breaks induced by common dental composites: In-vitro model10.2174/1874140101307010001 ↗